AzTrials
AzTrials

Bipolar DisorderNCT02120937

Mindfulness in Mood Dysregulated Youth

A study testing MBCT-C Therapy in people with Bipolar Disorder and Mood Disorder, run by University of Cincinnati at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Mindfulness group therapy can help children with mood irregularities and family history of bipolar disorder. Read more about this study

Who is it for?
Ages 10 to 17 years
What is being tested?
MBCT-C Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteUnited States
Study dates
Mar 2014to Mar 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • To be included in this study, subjects must meet the following criteria:
  • Ages 10 -17 years; inclusive at the time of consent
  • At least one biological parent with bipolar I disorder, confirmed with the SCID-P/L
  • CDRS-R score > 28 or YMRS score > 12 or ERC score > 36 at screening and baseline since clinically significant elevation on any of these scales suggests mood dysregulation
  • Fluent in English
  • Provision of written informed consent/assent as previously described
  • Agrees to participate in at least 75% of sessions.

Who cannot join

  • Previously documented diagnosis of mental retardation or an IQ <70
  • Any lifetime DSM-V diagnosis of bipolar disorder, schizophrenia or other psychotic disorder
  • Previous participation in a mindfulness-based treatment, including MBCT-C
  • A substance use disorder (except nicotine or caffeine) within the past 3 months
  • Judged clinically to be at risk from suicide as defined as having active suicidal ideation, intent or plan, or a serious suicide attempt within 30 days, or a baseline CDRS-R suicide score of >3
  • Concurrent treatment with psychotropic medications that have been adjusted during the 30 days prior to screening or are anticipated during the course of study participation
Show all 12Show fewer
  • Psychotherapy initiated within 2 month prior to screening or plan to initiate psychotherapy during study participation
  • Significant psychiatric symptoms that require hospitalization
  • Mood symptoms resulting from acute medical illness or acute intoxication or withdrawal from drugs or alcohol as determined by medical evaluation or rapid symptom resolution
  • Female patients who are either pregnant or lactating; All girls will have a urine pregnancy test prior to MR scans
  • Any contraindication to an MRI scan (e.g., metal clips, braces or claustrophobia)
  • Neurological disorders (e.g. epilepsy) or severe head trauma resulting in loss of consciousness for > 10 minutes or any unstable medical illness.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Cincinnati

    Cincinnati, Ohio, 45219

Other trials in United States

About this study

Official title: Neural Basis of Mindfulness in Mood Dysregulated Youth

Mindfulness group therapy can help children with mood irregularities and family history of bipolar disorder.

Read the detailed description

Mindfulness Based Cognitive Therapy (MBCT) is a manualized psychotherapeutic intervention that is a combination of mindfulness techniques and cognitive behavioral therapy. MBCT-C, which is mindfulness based cognitive based therapy for children, involves weekly group sessions, home practice, and the core curriculum of formal mindfulness practices (e.g. body scan, sitting, movement and walking meditations). Group sessions will involve guided meditation practices, instructor-led discussion of experiences and psychoeducation. By fopstering the ability to pay close attention to thoughts, emotions and body sensations, participants learn to make better choices to deal with stress, anxiety, depression, pain and other challenges. This can allow them to more effectively use the principles of cognitive behavioral therapy.

Twelve children aged 10-17 with mood dysregulation and a bipolar parent will be in the study for 12 weeks. There will be two groups receiving intervention: one group recruited from the community and one group recruited from a known high-risk cohort.

Being tested
MBCT-C Therapy
Keywords
amygdala, mindfulness, mood, emotion, bipolar disorder, parental bipolar disorder, adolescence
Medical subject headings
Bipolar Disorder, Mood Disorders, Affective Symptoms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MBCT-C TherapyBehavioural

    Also called Mindfulness Based Cognitive Therapy-Children

    Mindfulness Based Cognitive Therapy for Children is a manualized psychotherapeutic intervention that combines mindfulness techniques with certain features of cognitive behavioral therapy. This particular protocol for youth includes weekly group sessions, regular home practice, and the core curriculum of formal mindfulness practices (e.g., body scan, sitting, movement, and walking meditations).

Study groups in NCT02120937
Study groupRoleWhat they receive
MBCT-C TherapyExperimentalMindfulness Based Cognitive Therapy for Children is a manualized psychotherapeutic intervention that combines mindfulness techniques with certain features of cognitive behavioral therapy. This particular protocol for youth includes weekly group sessions, regular home practice, and the core curriculum of formal mindfulness practices (e.g., body scan, sitting, movement, and walking meditations).
Receives: Behavioral: MBCT-C Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in ERC

    Change from baseline to endpoint ( 12 weeks) in ratings on the Emotion Regulation Checklist

    Measured: 12 weeks

  2. Change in CDRS-R

    Change from baseline to endpoint (12 weeks) on the ratings on the Children's Depression Rating Scale-Revised.

    Measured: 12 weeks

  3. Change in YMRS

    Change from baseline to endpoint (12 weeks) in ratings on the Young Mania Rating Scale.

    Measured: 12 weeks

Secondary outcomes (1)
  1. Change in amygdala, insula, and prefrontal activation.

    We will examine baseline to endpoint changes in task related VLPFC, amygdala, and insula activation. We will examine associations among changes in activation in these brain regions and changes in mood regulation rating scale scores.Additionally, we will examine changes in seed-based resting state connectivity measures using amygdala and insula as the seeds and examining connectivity with VLPFC regions. Finally, we will use correlation to assess associations among changes in resting state connectivity of these regions and changes in mindfulness measures.

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Apr 2014 (estimated)
  2. Study startMar 2014
  3. Primary completionMar 2016
  4. Study completionMar 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02120937
Sponsor's protocol ID
2014-0453
Status last verified
Sep 2015
First submitted
18 Apr 2014
Last updated
18 May 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing MBCT-C Therapy in people with Bipolar Disorder and Mood Disorder, run by University of Cincinnati at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 May 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in ERC (time frame: 12 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in